Effects of In-Wheel Suspension

Sponsor
University of Pittsburgh (Other)
Overall Status
Recruiting
CT.gov ID
NCT04467749
Collaborator
The Craig H. Neilsen Foundation (Other)
30
1
1
19.5
1.5

Study Details

Study Description

Brief Summary

Manual wheelchairs allow individuals with spinal cord injuries (SCI) to safely and effectively access their environment. However, continual exposure to whole body vibration (WBV) is one of many contributing factors to neck pain, back pain, and fatigue in wheelchair users with SCI.

Vibration-reducing in-wheel suspension has the potential to mitigate issues associated with long-term manual wheelchair propulsion. Evidence is lacking on how well these systems work for reducing harmful shock and vibration, pain and fatigue. The purpose of this study is to examine how these wheels change the vibration levels manual wheelchair users are exposed to and how they impact pain and fatigue.

Condition or Disease Intervention/Treatment Phase
  • Other: Suspension Wheel
N/A

Detailed Description

Objective: The purpose of this project is to examine how Integral or in-wheel suspension impacts shock, vibration, pain and fatigue in manual wheelchair users with spinal cord injury who have chronic neck or back pain, defined as continuous or daily recurring pain that has been present for more than 3 months.

Experimental Design: This study consists of 2 phases. The first phase is a non-experimental post-test only design. The second phase is a non-experimental pretest-post-test design.

Methods: Thirty participants will be recruited to participate.

At Baseline (visit 1) participants will be asked to complete the study questionnaires and a standardized mobility course using a pair of standard wheelchair wheels (spoked rim), Spinergy lightweight carbon fiber wheels, and Loopwheels. Vibration exposure will be measured during the various propulsion tasks. The participant will be blinded to the type of wheel being used in the trial. Participants will be given a set of wheels (either Spinergy or Loopwheels) to use at home for the 12-week intervention.

Participants will use the in-wheel suspension wheels in their normal daily routine for 12-weeks. During this time, they will receive online surveys three times per week covering pain and fatigue experienced in various parts of the body.

At Closeout (Visit 2), participants will be asked to return to the lab to collect final outcomes, complete an exit survey and have their wheels swapped out for their original set.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
30 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Effects of In-wheel Suspension in Reducing Vibration, Neck, and Back Pain
Actual Study Start Date :
Jul 14, 2022
Anticipated Primary Completion Date :
Dec 23, 2023
Anticipated Study Completion Date :
Feb 28, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Suspension Wheel

Participants will be given a set of in-wheel suspension wheels to use in their normal daily routine for three months.

Other: Suspension Wheel
Participants will be given a pair of Spinergy or Loopwheels to use during the 12-week intervention period. The Spinergy wheels consist of a lightweight carbon fiber material with natural shock absorbing properties. Loopwheels offer a rigid rim, a mid-wheel shock absorbing hub and three in-wheel loops that work as a self-correcting system when encountering uneven ground.
Other Names:
  • Spinergy or Loopwheel
  • Outcome Measures

    Primary Outcome Measures

    1. Vibrational Dose Value (VDV) [Baseline Visit (Phase 1 Primary Outcome)]

      Amount of whole body vibration exposure in units of meters/sec to power of 1.75) computed using a 3-axis accelerometer attached to wheelchair on the obstacle course.

    2. Changes in Neck Pain [Baseline and 12-weeks (Phase 2 Primary Outcome)]

      Measured using the Numerical Rating Scale (NRS). The NRS measures amount of pain experienced in a body part over the last 24 hours on a scale of 0 = no pain to 10 = pain as bad as you can imagine.

    3. Changes in Upper Back Pain [Baseline and 12-weeks (Phase 2 Primary Outcome)]

      Measured using the Numerical Rating Scale (NRS). The NRS measures amount of pain experienced in a body part over the last 24 hours on a scale of 0 = no pain to 10 = pain as bad as you can imagine.

    4. Changes in Fatigue [Baseline and 12-weeks (Phase 2 Primary Outcome)]

      Measured using the Daily Questionnaire for Pain and Fatigue. Four questions ask specifically about fatigue experienced when using the wheelchair in and outside of the home and on smooth and uneven surfaces. The scale ranges from 0 = no fatigue to 3 = extreme fatigue.

    Secondary Outcome Measures

    1. Changes in Mobility Participation in the Community [Baseline and 12-weeks (Phase 2 Secondary Outcome)]

      Measured using Environmental Aspects of Mobility Questionnaire (EAMQ) a 36-item questionnaire accessing frequency of encounters and avoidances to environmental features. Each feature is scored on a 5-point scale (1=never, 2 = rarely, 3 = sometimes, 4=often, 5 = always). A separate total score is determined for Encounters ranging from 21 (never encounters any feature) to 105 (always encounters all features) and Avoidances ranging from 15 (never avoids any feature) to 75 (always avoids all features).

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • have neurological impairment secondary to a traumatic SCI

    • have a SCI which occurred or was diagnosed over one year prior to the start of the study

    • uses a manual wheelchair as a primary means of mobility (at least 30 hours per week but not necessarily always in motion)

    • uses a manual wheelchair with 24- or 25-inch quick release wheels

    • uses a manual wheelchair that does not have suspension elements in the frame,

    • weighs under 265 pounds (maximum weight limit of the suspension wheels),

    • has moderate chronic neck and/or back pain.

    • proficient in English

    Exclusion Criteria:
    • History of fractures or dislocations in the shoulder, elbow and wrist from which the participant has not fully recovered (i.e. the participant may no longer experience pain or limited/altered function due to the injury)

    • upper limb pain that interferes with the ability to propel,

    • severe cognitive limitations,

    • current or recent (within the last 6 months) history of pressure sores.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University of Pittsburgh Pittsburgh Pennsylvania United States 15206

    Sponsors and Collaborators

    • University of Pittsburgh
    • The Craig H. Neilsen Foundation

    Investigators

    • Principal Investigator: Alicia Koontz, PhD, University of Pittsburgh

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Alicia Koontz, Professor, University of Pittsburgh
    ClinicalTrials.gov Identifier:
    NCT04467749
    Other Study ID Numbers:
    • STUDY20020199
    First Posted:
    Jul 13, 2020
    Last Update Posted:
    Aug 5, 2022
    Last Verified:
    Aug 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    Yes
    Plan to Share IPD:
    Yes
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Aug 5, 2022